Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Prophylactic Tranexamic Acid on Perioperative Blood Loss in High-Risk Cesarean Delivery: A Randomized Controlled Study
Sponsor: Mert Yetgin
Summary
This randomized study evaluated whether prophylactic tranexamic acid (TXA) reduces perioperative blood loss in women at increased risk of postpartum hemorrhage undergoing elective cesarean delivery. Women aged 18-45 years with at least one risk factor for postpartum hemorrhage were included. The anesthesia technique, spinal or general anesthesia, was selected before randomization based on clinical considerations and patient preference. Within each anesthesia group, participants were randomized to receive either 1 g intravenous TXA after umbilical cord clamping or no TXA. The main outcome was estimated blood loss calculated from perioperative hematocrit values. Other outcomes included postpartum hemorrhage, blood transfusion, changes in hemoglobin and hematocrit, need for additional uterotonic medications, adverse events, and thromboembolic events during follow-up.
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
84
Start Date
2022-01-05
Completion Date
2023-02-05
Last Updated
2026-10-13
Healthy Volunteers
No
Conditions
Interventions
Tranexamic Acid
Participants assigned to the tranexamic acid groups received 1 g intravenous tranexamic acid administered slowly after umbilical cord clamping, concomitantly with the standardized oxytocin regimen.
Locations (1)
Pamukkale University Hospital
Denizli, Merkezefendi, Turkey (Türkiye)